ArticleBiochemistry and biophysics reports2025
Metformin interferes with urinary creatinine measurement using enzymatic method.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abnormal reaction curves were observed in urinary creatinine tests in patients with diabetes undergoing metformin therapy. Therefore, we investigated whether metformin interferes with urinary creatinine measurements. First, the reaction curves of urinary creatinine measurements from 328 patients were analyzed, focusing on the maximum reaction speed, final reaction speed, and their ratio. Next, the reaction curves of the creatinine solution with and without metformin were analyzed. To elucidate the mechanism of metformin interference, solutions of creatinine, creatine, sarcosine, and hydrogen peroxide with and without metformin were analyzed using a one-reagent measurement in which reagents 1 and 2 were pre-mixed. As the results, in the 84 patients taking metformin, the maximum reaction speed significantly decreased, whereas the final reaction speed and the ratio of the two speeds significantly increased (p < 0.001). Notably, the area under the curve of the ratio of the two speeds was 0.84 (95 % confidence interval: 0.78-0.89) for detecting metformin use, suggesting that metformin inhibits the series of reactions involved in creatinine measurement and that reaction curve analysis can identify metformin use. Similar results were obtained in experiments using metformin-containing creatinine solutions. Metformin did not interfere with the reactions involving sarcosine or hydrogen peroxide but did interfere with those involving creatinine and creatine, indicating that metformin inhibits creatinase activity. In conclusion, metformin inhibits reactions involved in urinary creatinine measurement in urine samples, potentially leading to falsely low urinary creatinine values and an inaccurate assessment of kidney function in patients with diabetes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.